🇺🇸 FDA
Pipeline program

Dexamethasone

ORT-2559-03928

Approved small_molecule active

Quick answer

Dexamethasone for Localized Primary Osteoarthritis of Both Hips (Diagnosis) is a Approved program (small_molecule) at Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Indication
Localized Primary Osteoarthritis of Both Hips (Diagnosis)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials